Edwards Lifesciences Overview
- Year Founded
-
1958
- Status
-
Public
- Employees
-
16,000
- Stock Symbol
-
EW
- Investments
-
47
- Share Price
-
$107.15
- (As of Friday Closing)
Edwards Lifesciences General Information
Description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Contact Information
Website
www.edwards.comCorporate Office
- One Edwards Way
- Irvine, CA 92614
- United States
Corporate Office
- One Edwards Way
- Irvine, CA 92614
- United States
Edwards Lifesciences Stock Performance
As of 13-Nov-2026, Edwards Lifesciences’s stock price is $107.15. Its current market cap is $61.6B with 575M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $107.15 | $105.80 | $74.66 - $107.69 | $61.6B | 575M | 3.81M | $1.77 |
Edwards Lifesciences Financials Summary
As of 30-Sep-2026, Edwards Lifesciences has a trailing 12-month revenue of $6.67B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 46,313,448 | 46,328,875 | 39,989,294 | 45,142,425 |
| Revenue | 6,674,700 | 6,067,600 | 5,439,500 | 5,010,000 |
| EBITDA | 1,467,700 | 1,281,100 | 1,602,800 | 1,467,700 |
| Net Income | 1,021,300 | 1,073,500 | 4,174,600 | 1,402,400 |
| Total Assets | 14,144,400 | 13,697,200 | 13,055,300 | 9,363,200 |
| Total Debt | 704,500 | 705,400 | 700,000 | 685,100 |
Edwards Lifesciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Edwards Lifesciences Comparisons
Industry
Financing
Details
Edwards Lifesciences Competitors (39)
One of Edwards Lifesciences’s 39 competitors is Integra LifeSciences Holdings, a Corporation company based in Princeton, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings | Corporation | Princeton, NJ | ||||
| Stryker | Formerly VC-backed | Portage, MI | ||||
| Boston Scientific | Corporation | Marlborough, MA | ||||
| Zimmer Biomet Holdings | Corporation | Warsaw, IN | ||||
| Teleflex | Corporation | Wayne, PA |
Edwards Lifesciences Patents
Edwards Lifesciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026232130-A1 | Left atrial appendage washout | Pending | 02-May-2025 | ||
| WO-2026231842-A1 | Docking devices for prosthetic heart valves | Pending | 30-Apr-2025 | ||
| WO-2026231552-A1 | Prosthetic heart valve with radially expandable skirt | Pending | 30-Apr-2025 | ||
| WO-2026231534-A1 | Sensor diaphragm bonding using transitional materials | Pending | 30-Apr-2025 | ||
| WO-2026226685-A2 | Devices and methods for crimping prosthetic implants | Pending | 24-Apr-2025 |
Edwards Lifesciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Edwards Lifesciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Edwards Lifesciences Investments & Acquisitions (47)
Edwards Lifesciences’s most recent deal was a Merger/Acquisition with Autus Valve Technologies for . The deal was made on 06-Feb-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Autus Valve Technologies | 06-Feb-2026 | Merger/Acquisition | Therapeutic Devices | ||
| Carvolix | 28-Jan-2026 | PIPE | Therapeutic Devices | ||
| Vectorious | 04-Sep-2025 | Secondary Transaction - Private | Monitoring Equipment | ||
| Innovalve | 01-Oct-2024 | Merger/Acquisition | Surgical Devices | ||
| Endotronix | 19-Aug-2024 | Merger/Acquisition | Enterprise Systems (Healthcare) |
Edwards Lifesciences ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
18.74 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Edwards Lifesciences Exits (19)
Edwards Lifesciences’s most recent exit was on 22-Sep-2020 from V-Wave. The exit was categorized as with 13 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| V-Wave | 22-Sep-2020 | Completed |
|
||
| Cardiovalve | 01-Aug-2020 | Completed |
|
||
| Caption Care | 15-Jul-2020 | Completed |
|
||
| Caption Care | 28-Apr-2020 | Completed |
|
||
| V-Wave | 11-Jan-2016 | Later Stage VC | Completed |
|
Edwards Lifesciences Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Vectorious | Tel Aviv, Israel | 2011 | |
| Valtech Cardio | Or Yehuda, Israel | 2005 | |
| Edwards Lifesciences 401(k) Savings and Investment Plan | Irvine, CA | 2000 |
Edwards Lifesciences FAQs
-
When was Edwards Lifesciences founded?
Edwards Lifesciences was founded in 1958.
-
Where is Edwards Lifesciences headquartered?
Edwards Lifesciences is headquartered in Irvine, CA.
-
What is the size of Edwards Lifesciences?
Edwards Lifesciences has 16,000 total employees.
-
What industry is Edwards Lifesciences in?
Edwards Lifesciences’s primary industry is Surgical Devices.
-
Is Edwards Lifesciences a private or public company?
Edwards Lifesciences is a Public company.
-
What is Edwards Lifesciences’s stock symbol?
The ticker symbol for Edwards Lifesciences is EW.
-
What is the current stock price of Edwards Lifesciences?
As of 13-Nov-2026 the stock price of Edwards Lifesciences is $107.15.
-
What is the current market cap of Edwards Lifesciences?
The current market capitalization of Edwards Lifesciences is $61.6B.
-
What is Edwards Lifesciences’s current revenue?
The trailing twelve month revenue for Edwards Lifesciences is $6.67B.
-
Who are Edwards Lifesciences’s competitors?
Integra LifeSciences Holdings, Stryker, Boston Scientific, Zimmer Biomet Holdings, and Teleflex are some of the 39 competitors of Edwards Lifesciences.
-
What is Edwards Lifesciences’s annual earnings per share (EPS)?
Edwards Lifesciences’s EPS for 12 months was $1.77.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
